These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7683835)

  • 1. Fixation method useful for cytologic examination and DNA flow cytometry of exfoliated bladder cells.
    Howell LP; Deitch AD; Andreotti VA; Westrick LA; White RD
    Urology; 1993 May; 41(5):472-5. PubMed ID: 7683835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinically applicable method to preserve urine and bladder washing cells for flow cytometric monitoring of bladder cancer patients.
    Deitch AD; Andreotti VA; Strand MA; Howell L; deVere White RW
    J Urol; 1990 Apr; 143(4):700-5. PubMed ID: 2179581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric study comparing paired bladder washing and voided urine for bladder cancer detection.
    Konchuba AM; Schellhammer PF; Alexander JP; Wright GL
    Urology; 1989 Feb; 33(2):89-96. PubMed ID: 2916296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine: a suitable sample for deoxyribonucleic acid flow cytometry studies in patients with bladder cancer.
    deVere White RW; Deitch AD; Baker WC; Strand MA
    J Urol; 1988 May; 139(5):926-8. PubMed ID: 3361665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA tetraploidy in Feulgen-stained bladder washings assessed by image cytometry.
    Kline MJ; Wilkinson EJ; Askeland R; Given RW; Stephen C; Hendricks JB
    Anal Quant Cytol Histol; 1995 Apr; 17(2):129-34. PubMed ID: 7542000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine or bladder washings in the cytologic evaluation of transitional cell carcinoma of the urinary tract. A comparison made under routine conditions supplemented by flow cytometric DNA analysis.
    Wijkström H; Lundh B; Tribukait B
    Scand J Urol Nephrol; 1987; 21(2):119-23. PubMed ID: 3616503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanol fixation of bladder irrigation specimens for flow cytometric analysis. A multiinstitutional study from the bladder cancer flow cytometry network.
    Hermansen DK; Melamed MR; Coon JS; Weinstein RS; White RD; Deitch AD; Wheeless LL; Reeder JE; Wersto R; Koss LG
    Cancer; 1989 May; 63(9):1780-3. PubMed ID: 2702585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of anticytokeratin 18 antibody to improve flow cytometric detection of bladder cancer.
    Konchuba AM; Clements MC; Schellhammer PF; Schlossberg SM; Wright GL
    Cancer; 1992 Dec; 70(12):2879-84. PubMed ID: 1280531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors.
    Meloni AM; Peier AM; Haddad FS; Powell IJ; Block AW; Huben RP; Todd I; Potter W; Sandberg AA
    Cancer Genet Cytogenet; 1993 Dec; 71(2):105-18. PubMed ID: 8281514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry versus urinary cytology in the diagnosis and follow-up of bladder tumors: critical review of a 5-year experience.
    Billerey C; Lamy B; Bittard H; Rozan S; Carbillet JP
    World J Urol; 1993; 11(3):156-60. PubMed ID: 8401634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acridine-orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder. The influence of prior local therapy.
    Têtu B; Katz RL; Kalter SP; von Eschenbach AC; Barlogie B
    Cancer; 1987 Oct; 60(8):1815-22. PubMed ID: 3652008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of DNA image cytometry and urinary cytology with cells from voided urine in the detection of bladder cancer.
    Planz B; Synek C; Robben J; Böcking A; Marberger M
    Urology; 2000 Nov; 56(5):782-6. PubMed ID: 11068301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive molecular detection of bladder cancer recurrence.
    Amira N; Mourah S; Rozet F; Teillac P; Fiet J; Aubin P; Cortesse A; Desgrandchamps F; Le Duc A; Cussenot O; Soliman H
    Int J Cancer; 2002 Sep; 101(3):293-7. PubMed ID: 12209982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple and practical technic for detecting cancer cells in urine and urinary bladder washings by flow cytometry.
    Pritchett TR; Kanzler AW; Nichols PW; Bakke AC; Hechinger MK; Skinner DG; Parker JW
    Am J Clin Pathol; 1985 Aug; 84(2):191-6. PubMed ID: 4025224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.
    Gilbert SM; Veltri RW; Sawczuk A; Shabsigh A; Knowles DR; Bright S; O'Dowd GJ; Olsson CA; Benson MC; Sawczuk IS
    Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometry of ethanol-fixed versus fresh bladder barbotage specimens.
    Ratliff JE; Klein FA; White FK
    J Urol; 1985 Jun; 133(6):958-60. PubMed ID: 3889375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
    Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
    Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image cytometric deoxyribonucleic acid analysis of urine specimens as an adjunct to visual cytology in the detection of urothelial cell carcinoma.
    Amberson JB; Laino JP
    J Urol; 1993 Jan; 149(1):42-5. PubMed ID: 8417214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality.
    Baak JP; Bol MG; van Diermen B; Janssen EA; Buhr-Wildhagen SB; Mestad O; Øgreid P; Kjellevold KH
    Urology; 2003 Jun; 61(6):1266-72. PubMed ID: 12809927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.